TMO Jan 2025 480.000 call
| Previous close | 122.20 |
| Open | 136.00 |
| Bid | 128.00 |
| Ask | 134.40 |
| Strike | 480.00 |
| Expiry date | 2025-01-17 |
| Day's range | 122.20 - 136.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 76 |
Business WireThermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass., May 22, 2024--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.39 per common share, payable on July 15, 2024, to shareholders of record as of June 14, 2024.
BenzingaUltragenyx Faces Lawsuit Over Alleged Unjust Use of Henrietta Lacks' Cells
The estate of Henrietta Lacks can proceed with a lawsuit against Ultragenyx Pharmaceutical (NASDAQ:RARE) over the use of cells taken from Lacks’ body in the 1950s, as ruled by a Maryland federal court on Monday. U.S. District Judge Deborah Boardman rejected Ultragenyx’s motion to dismiss the case, determining that the estate had plausibly claimed that Ultragenyx wrongly profited from its research using the “immortal” HeLa cell line. The HeLa cells, extracted from Lacks’ cervix without her knowle
Simply Wall St.Thermo Fisher Scientific Inc.'s (NYSE:TMO) Stock Is Going Strong: Is the Market Following Fundamentals?
Thermo Fisher Scientific (NYSE:TMO) has had a great run on the share market with its stock up by a significant 9.0...
